Skip to main content

Table 1 Clinical characteristics in overall treatments

From: Incidence and treatment outcomes of Graves’ disease in Thailand: a single-center retrospective observational study

Characteristics

Overall N = 302 (%)

Remission N = 133 (%)

Failure N = 169 (%)

Sex

 Female

205 (67.9%)

104 (78.2%)

101 (59.8%)

 Male

97 (32.1%)

29 (21.8%)

68 (40.2%)

 Mean Age (± SD) year

42.8 ± 15.1

42.6 ± 14.8

42.9 ± 15.5

Age group

  < 40 years

133 (44%)

61 (45.9%)

72 (42.6%)

  ≥ 40 years

169 (56%)

72 (54.1%)

97 (57.4%)

Thyroid function tests

 Median TSH uIU/ml

0.005

0.005

0.005

  (N 0.27–4.2 uIU/ml)

(IQR 0.005–0.01)

(IQR 0.005–0.013)

(IQR 0.005–0.01)

 Median FT3 ng/ml

14

13.8

14.8

  (N 0.93–1.71 ng/ml)

(IQR 8–22.8)

(IQR 6.5–23.1)

(IQR 8.7–22.8)

 Median FT4 pg/ml

4.6

4.3

5

  (N 2.0–4.4 pg/ml)

(IQR 3.1–7.2)

(IQR 2.6–6.7)

(IQR 3.3–7.6)

TSHa

  < 0.01 uIU/ml

207 (68.5%)

86 (64.7%)

121 (71.6%)

  ≥ 0.01 uIU/ml

87 (28.8%)

42 (31.3%)

45 (26.6%)

FT3a

  ≤ 3UNL

159 (52.6%)

74 (55.6%)

105 (49.3%)

  > 3UNL

142 (47%)

59 (44.4%)

107 (50.2%)

FT4a

  ≤ 3UNL

142 (47%)

68 (51.1%)

93 (43.7%)

  > 3UNL

112 (37.1%)

44 (33.1%)

87 (40.8%)

Extrathyroidal signs

 GO

39 (12.9%)

17 (12.8%)

22 (13%)

 Acropachy

1 (0.3%)

0 (0%)

1 (0.6%)

 TPP

14 (4.6%)

5 (3.8%)

9 (5.3%)

 AF

39 (12.9%)

16 (12%)

23 (13.6%)

 Pregnancy

8 (2.6%)

2 (1.5%)

6 (3.6%)

 Severe diseaseb

25 (8.3%)

10 (7.5%)

15 (8.9%)

 Heart failure

17 (5.6%)

8 (6%)

9 (5.3%)

 Hepatitis

2 (0.7%)

0 (0%)

2 (1.2%)

  1. aMissing data in 8 pt of TSH, 1 pt of FT3 and 48 pt of FT4
  2. bIncluding impending thyroid storm and thyroid storm
  3. UNL Upper normal limit, GO Graves’ orbitopathy, TPP Thyrotoxic periodic paralysis, AF Atrial fibrillation